Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000152

EVP, Chief Scientific Officer sold 3,231 shares at $510.00 ($1,647,810)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-13 Sale : show line 1 in the form 10b5-1 −3,231 $510.00 $1,647,810 23,281 D
Open-market sales · 3,231 sh · avg $510.00 · $1,647,810
Loading xslF345X05/wk-form4_1742242135.xml…